Statistics from Altmetric.com
We were pleased to learn of Moulis et al's update on their experience with abatacept in three patients with relapsing polychondritis, particularly as their disease manifestations reflected the same manifestations suggested in our study to be of greatest interest for abatacept: chondritis and peripheral arthritis.1 Interestingly, one patient achieved a complete, while another achieved only a partial, corticosteroid-sparing response, and …
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.